RxSight (RXST) Fell Due to Missed Expectations and Guidance Reduction
Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” second quarter 2025 investor letter.
Rxsight Inc. (RXST)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 3,702,967 | $48,138,571 | -2% | 0.81% |
| 2. | D E Shaw D. E. Shaw | 1,321,330 | $17,177,290 | +5907% | 0.01% |
| 3. | No Street Capital Jeff Osher | 1,200,000 | $15,600,000 | +100% | 1.15% |
| 4. | Citadel Investment Group Ken Griffin | 1,027,863 | $13,362,219 | +347% | 0% |
| 5. | Millennium Management Israel Englander | 951,177 | $12,365,301 | +6% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $31.13 | 1,767 | $55,004.24 | 3,210 | 2025-01-16 | Filing | |
| $31.19 | 1,443 | $44,999.96 | 1,443 | 2025-01-15 | Filing | |
| $44.50 | 1,705 | $75,872.50 | 38,438 | 2024-11-13 | Filing | |
| $44.98 | 4,090 | $183,968.20 | 36,733 | 2024-11-13 | Filing | |
| $45.00 | 5,570 | $250,650.00 | 474,141 | 2024-11-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.71 | 7,000 | $180,001.50 | 24,793 | 2025-03-12 | Filing | |
| $30.87 | 3,519 | $108,618.16 | 7,383 | 2025-01-22 | Filing | |
| $46.08 | 3,105 | $143,078.40 | 42,246 | 2024-11-29 | Filing | |
| $45.88 | 3,782 | $173,518.16 | 10,902 | 2024-11-26 | Filing | |
| $45.88 | 3,100 | $142,228.00 | 42,246 | 2024-11-26 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 94,063 | $845,626 | 0% | |
| 2. | 220 | $1,978 | 0% |
News See All
RxSight, Inc. (NASDAQ:RXST) Q2 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. My name is Desiree, and I will be your conference operator today.
Wells Fargo Upgrades RxSight (RXST), Sees LAL Technology as Undervalued
Wells Fargo upgraded RxSight Inc. (NASDAQ:RXST) from Equal Weight to Overweight on Monday, while raising its price target from $17 to $25 due to an attractive valuation at the current stock price.
RxSight, Inc. (NASDAQ:RXST) Q4 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. My name is Desiree, and I will be your conference operator today. At this time, I would like to welcome everyone to RxSight, Inc.
Do You Believe in the Long-Term Growth Potential of RxSight (RXST)?
Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded...
RxSight, Inc. (NASDAQ:RXST) Q3 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Andrea, and I will be your conference operator today.
10 Most Promising Small-Cap Stocks According to Hedge Funds
Small-cap stocks are offering a myriad of opportunities to investors and are expected to go higher.
Top Investors' Stock Portfolio: 7 Small-Cap Stocks to Invest In
The market experts opine that strong and stable earnings growth, a favourable valuation environment and the expectation of lower interest rates provide a supportive environment for global small-cap equities...
RxSight, Inc. (NASDAQ:RXST) Q2 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the RxSight Second Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
RxSight, Inc. (NASDAQ:RXST) Q1 2024 Earnings Call Transcript
RxSight, Inc. misses on earnings expectations. Reported EPS is $-0.24699 EPS, expectations were $-0.17.